Dr Christopher McNamara: Haematology

Covid-19

Hospitals are starting to offer more treatment for private patients, although a very small number will continue to provide NHS care only. Hospitals will need to catch up on all the treatment that was postponed at the start of the outbreak. If you’re due to see a Bupa recognised healthcare professional, we recommend you discuss this with them as they’ll be best placed to let you know whether there’s likely to be any impact on your treatment. Hospitals are taking extra precautionary steps to keep patients safe, such as asking them to self-isolate for 14 days before treatment and pre-admission testing. For our latest updates, support and guidance visit our COVID-19 information hub.

Not Fee assured
Verified this account

Overview

COVID-19

This healthcare professional let us know that they are currently available for:

Face-to-face consultations
Phone consultations
Video consultations

Last updated: 12 Nov 2020

About me

Dr Christopher McNamara is a consultant haematologist with a special interest in lymphoma and difficult diagnostic problems. He holds Fellowships of the Royal Australasian College of Physicians and Pathologists and the Royal College of Pathologists. His post-graduate training was in Brisbane, Melbourne and Paris. He has held an NHS appointment, based in lymphoma work, at London university teaching hospitals for the last 16 years.

Dr McNamara is involved in applied clinical research in the lymphoma field as well as national and international clinical trials. A publication record can be provided on request.

Areas of interest

Follicular lymphoma, diffuse large B-cell lymphoma, Hodgkin lymphoma, marginal zone lymphoma, mantle cell lymphoma, abnormal blood counts and their investigation.

Medical secretaries

Ms Leighann Dennis
020 7908 2103
020 7486 5412
pa@londonhaematologist.com

About me

My qualifications & training

My private practice

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

X0004
Clinical supervision and planning for delivery of chemotherapy cycle 1 - 28 days - (>50)

HCA Healthcare UK @ UCH Private Care (5-50) Royal Free Hospital (5-50)
X3570
Therapeutic venesection - (5-50)

HCA Healthcare UK @ UCH Private Care (5-50) Princess Grace Hospital (1-5)
X0003
Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (5-50)

HCA Healthcare UK @ UCH Private Care (5-50)
X3590
Intravenous infusion (as sole procedure) - (5-50)

HCA Healthcare UK @ UCH Private Care (5-50) Princess Grace Hospital (5-50) Royal Free Hospital (1-5)
X0001
Clinical supervision and planning for the delivery of chemotherapy regimens for 0 to 7 days - (5-50)

HCA Healthcare UK @ UCH Private Care (5-50)
W3650
Diagnostic aspiration and trephine biopsy of bone marrow, including analysis - (5-50)

HCA Healthcare UK @ UCH Private Care (5-50)
XR120
CT/MRI guided biopsy(ies) - (1-5)

Princess Grace Hospital (1-5)
X0002
Clinical supervision and planning for delivery of chemotherapy cycle 1 - 14 days - (1-5)

HCA Healthcare UK @ UCH Private Care (1-5)
XR915
Insertion of central venous catheter - tunnelled (x-ray guided) - (1-5)

HCA Healthcare UK @ UCH Private Care (1-5)
XR110
Ultrasound guided biopsy(ies) - (1-5)

Princess Grace Hospital (1-5)
XR180
Ultrasound guided drainage of fluid collection - (1-5)

HCA Healthcare UK @ UCH Private Care (1-5)
Show All (11)...

Finder

Covid-19

Note: